| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/04/24 | 21 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/04/02 | 05 : 15 | GlobeNewswire Inc. | Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/28 | 22 : 32 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/25 | 21 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/21 | 21 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/20 | 21 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/19 | 21 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024 | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/12 | 21 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/11 | 21 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/11 | 21 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/07 | 23 : 37 | GlobeNewswire Inc. | New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/07 | 22 : 06 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/07 | 22 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/07 | 07 : 01 | Edgar (US Regulatory) | Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/06 | 22 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/06 | 22 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/05 | 22 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/05 | 22 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/01 | 07 : 08 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/01 | 07 : 07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/01 | 07 : 06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/03/01 | 07 : 05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/02/29 | 22 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/02/28 | 22 : 06 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/02/28 | 22 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/02/27 | 22 : 07 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/02/27 | 22 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/02/23 | 23 : 30 | GlobeNewswire Inc. | New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/02/20 | 22 : 00 | GlobeNewswire Inc. | Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |
| 2024/02/16 | 23 : 30 | GlobeNewswire Inc. | New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT | NASDAQ:TNXP | Tonix Pharmaceuticals Holding Corporation |